Your clients have a cancer problem they don’t know about yet.
60% of employees with hereditary cancer risk will never qualify for testing through insurance. LifeShield gives brokers a turnkey program to close that gap — and get paid to do it.
- 4-week implementation, zero HR integration
- 27–50% voluntary employee participation
- Referral fee for each placement + recurring commission
Why brokers add LifeShield
A benefit that generates renewal loyalty — and pays a commission while it does it.
First-mover differentiation
Fertility benefits. Mental health. Hereditary cancer is next. The brokers who move early lock in renewal loyalty before this becomes standard.
Most brokerages aren’t offering this yet
CFO-level ROI math
One early-stage cancer identification saves ~$190,000 in claims versus late-stage. That math passes the CFO test without a committee presentation.
~$190K average savings per early detection
Zero administrative burden
LifeShield handles employee communications, onboarding, and all clinical coordination. HR’s total time commitment: one 30-minute kickoff call.
< 2 hours of HR time to launch
You get paid — transparently
Referral fee for every employer you place, plus ongoing recurring commission. All compensation is fully disclosed to plan fiduciaries per CAA 2021 — LifeShield provides the templated disclosure language, no additional compliance work required.
Referral fee per placement + recurring commission
27–50%
Voluntary participation in comparable programs
~$190K
Average savings per early-stage identification
4 weeks
From signed contract to employees live
$0
Out-of-pocket for employees when employer-sponsored
How it works for your clients
The employer commits. Employees self-enroll. LifeShield handles everything else.
You refer
Introduce LifeShield to a self-insured employer client. LifeShield sends a proposal and handles the full sales conversation with HR.
Live in 4 weeks
LifeShield sets up an employer-branded portal, drafts all employee communications, and configures the platform. One kickoff call from HR.
Employees self-enroll
A 5-minute AI-guided family history assessment identifies who has genuine hereditary cancer risk — confidentially, at their own pace, on any device.
Outcomes tracked
Qualifying employees access counseling and at-home genetic testing. HR receives only aggregate reports. You receive your recurring commission monthly.
The cost argument your clients already understand
Self-insured employers live this math. You don’t need to explain it — just show it.
When caught early
- ~$50K–$80K treatment cost
- 95%+ five-year survival rate
- Outpatient surgery + monitoring
- Minimal work disruption
When diagnosed late
- ~$250K+ treatment cost
- ~50% five-year survival rate
- Chemo + radiation + surgery
- Extended leave + disability claim
For a 1,000-person employer, even 2–3 early detections per year save more than the entire annual program cost.
Questions brokers ask
Ready to add hereditary cancer screening to your book?
Book a 20-minute discovery call. We’ll cover the economics, build a custom ROI model for one of your clients, and discuss founding partner pricing.
Questions? contact@lifeshield.ai